In India, recent rulings to deny patent protection for drugs manufactured by Western pharmaceutical firms have cast doubt on whether the industry can make a profit in the world's second-most[…]
The Indian Supreme Court's rejection of an appeal for patent protection by Swiss pharmaceutical firm Novartis has reignited debate over how generic drugs should be regulated in the nation, and[…]